CJC-1295 DAC – Aliquot, 5mg
Data Sheet
| Application | Binds to GHRH receptors in the pituitary gland |
| CAS | 446262-90-4 |
| Molar Mass | 3647.25 g/mol |
| Chemical Formula | C165H269N47O46 |
| Amino Acid Sequence | YADAIFTQSYRKVLAQLSARKLLQDILSR |
| Synonyms | CJC 1295 with DAC, Modified GRF (1-29), DAC:GRF acetate, CJC-1295 acetate, TS-10609 |
| Storage | Store at ≤4°C, tightly sealed, away from heat, light and moisture. |
| Solubility | Soluble in BAC Water |
| Organoleptic Profile | White powder in 3mL glass aliquot |
| Composition | Each aliquot contains CJC-1295 DAC, Acetate |
| Specification | CJC-1295 DAC content (per aliquot): CJC-1295 DAC 5mg ±10% |
| Terms | This material is sold for laboratory research use only. Terms of sale apply. Not for human consumption, nor medical, veterinary, or household uses. Please familiarize yourself with our Terms & Conditions prior to ordering. |
Long-Acting GHRH Analogue Peptide for Growth Hormone Research
CJC-1295 DAC is a research-grade synthetic peptide widely studied for its potential relevance in growth hormone-releasing hormone (GHRH) signaling, pituitary-endocrine pathway research, extended GH secretion models, and peptide endocrinology investigations. As a Drug Affinity Complex (DAC)-modified GHRH analogue, CJC-1295 DAC has attracted significant scientific interest in studies involving GH/IGF-associated pathways, sustained growth factor signaling, and metabolic physiology research.
Researchers have investigated CJC-1295 DAC in models involving GHRH receptor-mediated mechanisms, endocrine signaling pathways, prolonged peptide activity research, and peptide-mediated metabolic studies. Its investigational profile has made it a notable compound in advanced peptide science.
Supplied as a laboratory-grade aliquot for analytical and research applications.
Common Research Areas
- GHRH Signaling Research
- Growth Hormone Axis Studies
- Pituitary-Endocrine Investigation
- Sustained Growth Factor Models
- Peptide Research Applications
How CJC-1295 DAC Works
CJC-1295 DAC has been studied for its potential interaction with pathways associated with GHRH receptor signaling, pituitary regulation, and growth factor biology. Researchers have explored its relevance in models involving prolonged GH-associated mechanisms, endocrine signaling pathways, and peptide-mediated metabolic regulation.
Its modified long-acting peptide profile has made it a recurring subject in advanced research science.
Research Overview
CJC-1295 DAC has been investigated across a range of research models involving endocrine biology, growth factor signaling, and metabolic pathways.
Areas of scientific interest include:
- GHRH pathway studies
- Pituitary signaling investigations
- Growth factor research models
- Sustained endocrine regulation studies
- Peptide pathway research
Its broad research relevance continues to make it a notable compound in peptide science.
CJC-1295 DAC vs Related Compounds
CJC-1295 DAC vs CJC-1295 No DAC
CJC-1295 DAC is often researched for extended-duration GHRH signaling models, while No DAC variants are commonly investigated in pulsatile secretion pathway studies.
CJC-1295 DAC vs Tesamorelin
Tesamorelin has drawn interest as a distinct modified GHRH analogue, whereas CJC-1295 DAC is more strongly associated with prolonged peptide signaling investigations.
Frequently Asked Questions
What is CJC-1295 DAC studied for?
It is commonly researched in GHRH signaling, growth hormone pathways, pituitary-endocrine regulation, and metabolic-associated models.
What does DAC mean?
DAC stands for Drug Affinity Complex, referring to the modification associated with prolonged investigational activity.
How should CJC-1295 DAC be stored?
Lyophilized peptide aliquots are generally stored refrigerated according to laboratory handling protocols.
